文献速递脑血管病

急性前循环串联病变急诊颈动脉支架置入的多中心研究

Emergent Carotid Stenting for Acute Anterior Circulation Ischemic Stroke With Tandem Lesions: The Multicenter CERES-TANDEM Study.
PubMed 文献 · Neurology · 2025-12-26

CERES-TANDEM多中心回顾性队列纳入4053例前循环串联病变卒中患者,比较血管内取栓联合急诊颈动脉支架置入与不置入支架的90天功能结局。IPTW加权分析显示eCAS与90天功能结局改善相关(共同OR 1.31,95%CI 1.17-1.47,P<0.001),且症状性颅内出血无显著增加。

要点

  • eCAS与90天mRS改善独立相关,共同OR 1.31(95%CI 1.17-1.47)。
  • eCAS组mRS 0-1和0-2的比值比分别为1.27和1.30,均显著。
  • 症状性颅内出血风险未显著增加(OR 1.21,95%CI 0.93-1.56)。

核心结论

  • 在前循环串联病变的血管内取栓中,急诊颈动脉支架置入与90天功能恢复更优相关,且不增加出血风险。

研究设计与样本

  • 共纳入4053例前循环急性缺血性卒中串联病变患者,平均年龄70岁,女性占65.5%;其中2522例接受eCAS,1531例未置入支架。

主要发现

  • IPTW加权后,eCAS与90天功能结局改善相关(共同OR 1.31;95%CI 1.17-1.47;P<0.001)。
  • eCAS与mRS 0-1(OR 1.27;95%CI 1.08-1.50;P=0.005)和mRS 0-2(OR 1.30;95%CI 1.13-1.51;P<0.001)的更高 odds 相关。
  • 症状性颅内出血无显著增加(OR 1.21;95%CI 0.93-1.56;P=0.15)。
  • 直接效应估计(共同OR 1.17;95%CI 1.04-1.31;P=0.008)和分层估计(共同OR 1.37;95%CI 1.21-1.55;P<0.001)结果一致。

关键数值与推荐

  • 主要估计目标为mRS移位,采用稳定逆概率治疗加权(IPTW)有序回归分析。
  • 成功再通定义为脑梗死溶栓分级2b或以上。

临床怎么用

  • 对于前循环串联病变急性缺血性卒中患者,在血管内取栓过程中可考虑急诊颈动脉支架置入以改善90天功能结局。

局限性

  • 本研究为回顾性队列研究,证据等级为Class II,结论需随机对照试验进一步证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The management of anterior circulation tandem lesion stroke remains controversial, given its under-representation in randomized thrombectomy trials and uncertainty regarding optimal extracranial carotid intervention. We aimed to determine whether emergent carotid stenting (eCAS) during endovascular thrombectomy (EVT) for anterior circulation tandem lesions improves 90-day functional outcomes compared with a no-stenting strategy. METHODS: We conducted an international multicenter longitudinal retrospective cohort study (CERES-TANDEM, NCT06965036) of consecutive adults treated at 49 comprehensive stroke centers in Europe, North America, and Singapore for anterior circulation acute ischemic stroke due to tandem lesions from January 1, 2018, to December 31, 2024. Exclusion criteria were primary hemorrhagic stroke, absence of intracranial occlusion, presentation >24 hours from symptom onset, and age younger than 18 years. We compared 90-day modified Rankin Scale (mRS) scores between participants receiving eCAS and those receiving no stenting during EVT. The primary estimand was mRS shift, analyzed by stabilized inverse probability of treatment weighting (IPTW)-weighted ordinal regression. Additional estimands were direct-effect estimand adjusting for successful recanalization (defined as Thrombolysis in Cerebral Infarction grade 2b or higher) and symptomatic intracranial hemorrhage (sICH) (estimand 2) and stratum estimand restricting to never-crossers (estimand 3). RESULTS: Of 4,053 patients (mean age 70 years, 65.5% female), 2,522 underwent eCAS and 1,531 received no stenting. After IPTW, eCAS was associated with an improved 90-day functional outcome (common odds ratio (OR) 1.31; 95% CI 1.17-1.47;p < 0.001) and higher odds of mRS score 0-1 (OR 1.27; 95% CI 1.08-1.50; p = 0.005) and mRS score 0-2 (OR 1.30; 95% CI 1.13-1.51; p < 0.001), without a significant increase in sICH (OR 1.21; 95% CI 0.93-1.56; p = 0.15). Findings were consistent in direct-effect (common OR 1.17; 95% CI 1.04-1.31; p = 0.008) and stratum (common OR 1.37; 95% CI 1.21-1.55; p < 0.001) estimands. There was no interaction for intracranial occlusion site, IV thrombolysis, sedation technique, EVT approach, or access site. Sensitivity analysis including recanalization in IPTW-weighted estimand 1 framework confirmed the association of eCAS with improved 90-day functional outcomes (common OR 1.14, 95% CI1.02-1.27, p = 0.008). DISCUSSION: In this large real-world cohort, eCAS during EVT for anterior circulation tandem lesions was associated with superior 90-day functional recovery without increased hemorrhagic risk. These findings support consideration of eCAS in clinical practice and warrant confirmation in randomized trials. TRIAL REGISTRATION INFORMATION: Registered in clinicaltrials.gov, NCT06965036. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with stroke due to anterior circulation tandem lesions, eCAS during EVT improves 90-day functional outcomes compared with EVT alone.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Romoli M, Molina CA, Zapata-Arriaza E, et al. Emergent Carotid Stenting for Acute Anterior Circulation Ischemic Stroke With Tandem Lesions: The Multicenter CERES-TANDEM Study. Neurology. 2025. PMID: 41453121. doi:10.1212/WNL.0000000000214528

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。